• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconFeatured

Featured

Page 67 of 67
Sam Altman’s ouster brings EU regulatory debates into the limelight: ‘We cannot rely on voluntary agreements brokered by visionary leaders’
TechSam Altman’s ouster brings EU regulatory debates into the limelight: ‘We cannot rely on voluntary agreements brokered by visionary leaders’
By ReutersNovember 21, 2023
Britain’s next government will need to raise taxes to tackle an aging population and a surge in borrowing costs
RetailBritain’s next government will need to raise taxes to tackle an aging population and a surge in borrowing costs
By ReutersNovember 20, 2023
How a Danish wind company caught the ire of Donald Trump and took a $4 billion write-off in its ‘biggest pain point’—the U.S.
EnvironmentHow a Danish wind company caught the ire of Donald Trump and took a $4 billion write-off in its ‘biggest pain point’—the U.S.
By Ryan HoggNovember 17, 2023
Avon survived on door-to-door sales for 137 years. Now, it’s opening its first U.K. stores because its customers have given up being at home
RetailAvon survived on door-to-door sales for 137 years. Now, it’s opening its first U.K. stores because its customers have given up being at home
By Ryan HoggNovember 14, 2023
Novo Nordisk faces first real test as Eli Lilly wins approval for a weight loss-aiding drug—and it’s nearly $300 cheaper than Wegovy
RetailNovo Nordisk faces first real test as Eli Lilly wins approval for a weight loss-aiding drug—and it’s nearly $300 cheaper than Wegovy
By Ryan HoggNovember 9, 2023
Employees using 3d-printed cement on a housing development in Kenya.
EnvironmentThe construction industry has been a major climate-change offender. This Swiss company’s cement and concrete could help builders get greener
By Peter VanhamNovember 8, 2023
Europe’s most valuable drugmaker Novo Nordisk is threatening the EU with a shift to the U.S.
HealthEurope’s most valuable drugmaker Novo Nordisk is threatening the EU with a shift to the U.S.
By Ryan HoggNovember 6, 2023
Brands like Walmart and Nestle are right to worry about Wegovy. Novo Nordisk sold $900m of the weight loss drug last quarter—and 95% was in the U.S.
HealthBrands like Walmart and Nestle are right to worry about Wegovy. Novo Nordisk sold $900m of the weight loss drug last quarter—and 95% was in the U.S.
By Ryan HoggNovember 2, 2023
More millionaires are expected to leave China this year than any other country, as the end of COVID-zero allows them to finally relocate
FinanceMore millionaires are expected to leave China this year than any other country, as the end of COVID-zero allows them to finally relocate
By Nicholas GordonJune 14, 2023
1...
  • 63
  • 64
  • 65
  • 66
  • 67
67
Most Popular
Innovation
Google CEO Sundar Pichai says we’re just a decade away from a new normal of extraterrestrial data centersplaceholder alt text
By Fortune EditorsApril 3, 2026
North America
The World Cup is supposed to be an economic windfall. But 'you're seeing a number of headwinds' nowplaceholder alt text
By Fortune EditorsApril 4, 2026
Real Estate
Gen Z fled San Francisco for Texas and Florida. Now they’re turning ‘welcomer cities’ into the next big tech townsplaceholder alt text
By Fortune EditorsApril 2, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.